Sign in

CIK 0000727510

  • Non-accelerated filer
  • Smaller reporting company

Viskase Holdings, Inc.

Sign in to watch
Ticker
VISK
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222372868
Phone
+1 630-874-0700
Business address
333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
Former names
ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
  1. 4 Shares withheld for taxes Chairman, CEO & President gave up 16,362 shares (to pay taxes)
  2. 4 Option exercise Exec. Vice Pres. HR acquired 3,000 shares (option exercise)
  3. 4 Shares withheld for taxes EVP, R&D, Chief Sci. Officer gave up 797 shares (to pay taxes)
  4. 4 Option exercise EVP-Technical Operations acquired 3,000 shares (option exercise)
  5. 4 Shares withheld for taxes EVP, R&D, Chief Sci Officer gave up 5,313 shares (to pay taxes)
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 4 Option exercise Director acquired 4,279 shares (option exercise)
  9. 4 Option exercise Director acquired 4,279 shares (option exercise)
  10. 4 Option exercise Director acquired 4,279 shares (option exercise)
  11. 4 Option exercise Director acquired 4,279 shares (option exercise)
  12. 4 Option exercise Director acquired 4,279 shares (option exercise)
  13. 4 Grant or award Director acquired 10,432 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Grant or award Director acquired 10,432 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Shares withheld for taxes EVP, Technical Operations gave up 1,594 shares (to pay taxes)
  18. 4 Option exercise Exec. Vice Pres. HR acquired 4,500 shares (option exercise)
  19. 4 Shares withheld for taxes Exec VP Finance, CFO gave up 1,594 shares (to pay taxes)
  20. 4 Open-market sale Exec VP Finance, CFO sold 5,930 shares at $6.12 ($36,292)

Page 10 of 28 · 560 filings